These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4815966)

  • 1. Analysis of phenylbutazone in plasma by high-speed liquid chromatography.
    Pound NJ; McGilveray IJ; Sears RW
    J Chromatogr; 1974 Feb; 89(1):23-30. PubMed ID: 4815966
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous determination of phenylbutazone and oxyphenbutazone in plasma by high-speed liquid chromatography.
    Pound NJ; Sears RW
    J Pharm Sci; 1975 Feb; 64(2):284-7. PubMed ID: 1127584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The assay of phenylbutazone in human plasma by a specific and sensitive gas-liquid chromatographic procedure.
    McGilveray IJ; Midha KK; Brien R; Wilson L
    J Chromatogr; 1974 Feb; 89(1):17-22. PubMed ID: 4815964
    [No Abstract]   [Full Text] [Related]  

  • 4. Faster extraction of phenylbutazone from blood and plasma.
    Stevens HM
    Clin Chem; 1970 May; 16(5):437-40. PubMed ID: 5443770
    [No Abstract]   [Full Text] [Related]  

  • 5. GLC determination of plasma concentration of phenylbutazone and its metabolite oxyphenbutazone.
    Midha KK; McGilveray IJ; Charette C
    J Pharm Sci; 1974 Aug; 63(8):1234-9. PubMed ID: 4852201
    [No Abstract]   [Full Text] [Related]  

  • 6. Simultaneous determination of phenylbutazone and its metabolites in plasma and urine by high-performance liquid chromatography.
    Marunaka T; Shibata T; Minami Y; Umeno Y
    J Chromatogr; 1980 Sep; 183(3):331-8. PubMed ID: 7419650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-phase extraction for the high-performance liquid chromatographic determination of indomethacin, suxibuzone, phenylbutazone and oxyphenbutazone in plasma, avoiding degradation of compounds.
    Caturla MC; Cusido E
    J Chromatogr; 1992 Oct; 581(1):101-7. PubMed ID: 1429991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of furosemide, phenylbutazone and oxyphenbutazone in plasma by direct injection onto internal surface reversed-phase columns with systematic optimization of selectivity.
    Pinkerton TC; Perry JA; Rateike JD
    J Chromatogr; 1986 Oct; 367(2):412-8. PubMed ID: 3782354
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of lead exposure on plasma phenylbutazone levels in rats.
    Basu N; Kulsreshtha T
    Indian J Physiol Pharmacol; 1994 Jan; 38(1):61-2. PubMed ID: 8132249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quantitative autoanalysis of phenolic acids by liquid chromatography on a polyclar column and ultraviolet spectrophotometry].
    Alibert G
    J Chromatogr; 1973 Jun; 80(2):173-85. PubMed ID: 4723043
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of phenylbutazone in plasma.
    Jähnchen E; Levy G
    Clin Chem; 1972 Sep; 18(9):984-6. PubMed ID: 5052102
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of bumadizone, phenylbutazone and oxyphenbutazone in human plasma by high-performance liquid chromatography (author's transl)].
    Spahn H; Mutschler E
    Arzneimittelforschung; 1981; 31(3):495-9. PubMed ID: 6894379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The analysis of estrogenic steroids in urine by high-speed liquid chromatography.
    Dolphin RJ
    J Chromatogr; 1973 Aug; 83():421-30. PubMed ID: 4354840
    [No Abstract]   [Full Text] [Related]  

  • 14. The determination of phenylbutazone in horse plasma.
    Bogan JA
    Vet Rec; 1972 Feb; 90(7):199. PubMed ID: 5062941
    [No Abstract]   [Full Text] [Related]  

  • 15. Phenylbutazone: plasma concentrations and effectiveness in patients with rheumatoid arthritis.
    Orme ML
    J Int Med Res; 1977; 5 Suppl 2():40-7. PubMed ID: 913873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical studies into the nature of the high affinity binding site of human serum albumin for phenylbutazone.
    Maes V; Hoebeke J; Vercruysse A; Kanarek L
    Mol Pharmacol; 1979 Jul; 16(1):147-53. PubMed ID: 481416
    [No Abstract]   [Full Text] [Related]  

  • 17. Binding of phenylbutazone to human serum albumin. Characterization and identification of binding sites.
    Russeva V; Mihailova D
    Arzneimittelforschung; 1999 Mar; 49(3):255-8. PubMed ID: 10219470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentration of phenylbutazone and its therapeutic effect-studies in patients with rheumatoid arthritis.
    Orme M; Holt PJ; Hughes GR; Bulpitt CJ; Draffan GH; Thorgeirsson SS; Williams F; Davies DS
    Br J Clin Pharmacol; 1976 Feb; 3(1):185-91. PubMed ID: 788739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous analysis of flunixin, naproxen, ethacrynic acid, indomethacin, phenylbutazone, mefenamic acid and thiosalicylic acid in plasma and urine by high-performance liquid chromatography and gas chromatography-mass spectrometry.
    Singh AK; Jang Y; Mishra U; Granley K
    J Chromatogr; 1991 Aug; 568(2):351-61. PubMed ID: 1783641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An improved HPLC assay for monitoring phenylbutazone and its two major oxidised metabolites in plasma.
    Aarons L; Higham C
    Clin Chim Acta; 1980 Aug; 105(3):377-82. PubMed ID: 7408197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.